Anti-PCSK9 Reference Antibody (evolocumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Mouse, Cynomolgus |
Conjugation | Unconjugated |
Anti-PCSK9 Reference Antibody (evolocumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Mouse, Cynomolgus |
Conjugation | Unconjugated |
Anti-PCSK9 Reference Antibody (alirocumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Mouse, Cynomolgus |
Conjugation | Unconjugated |
Anti-PCSK9 Reference Antibody (recaticimab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Mouse, Cynomolgus |
Conjugation | Unconjugated |
Anti-PCSK9 Reference Antibody (RG7652)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Mouse, Cynomolgus |
Conjugation | Unconjugated |
Anti-PCSK9 Reference Antibody (lodelcizumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Mouse, Rat, Cynomolgus |
Conjugation | Unconjugated |
Anti-PCSK9 Reference Antibody (ongericimab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |
Conjugation | Unconjugated |
Anti-PCSK9 Reference Antibody (tafolecimab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Mouse, Cynomolgus |
Conjugation | Unconjugated |
Anti-PCSK9 Reference Antibody (bococizumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Mouse, Cynomolgus |
Conjugation | Unconjugated |
Anti-PCSK9 Reference Antibody (ebronucimab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Mouse, Cynomolgus |
Conjugation | Unconjugated |
Anti-PCSK9 Reference Antibody (Boehringer anti-PCSK9)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |
Conjugation | Unconjugated |